Resident/Fellow Paper Day
Tuesday, March 24, 2009
| 8:00 a.m. – 8:15 a.m. | Introduction | Dr. Theodore Jones |
| 8:15 a.m. – 8:30 a.m. | “Impact of 18 fluro-2-deoxy-glucose positron emission tomography FDG-PET) imaging on therapeutic decision making in patients with recurrent ovarian carcinoma” | Dr. Helard Ballon-Hennings |
| 8:30 a.m. – 8:45 a.m. | “Evaluation of combined colposcopy, biopsy and cytology correlation conference in a university hospital” | Dr. Gunjal Garg |
| 8:45 a.m. – 9:00 a.m. | “Role of natural killer lymphocyte NKG2D receptor pathway in adhesion development” | Dr. Zeynep Alpay |
| 9:00 a.m. – 9:15 a.m. | “Prognosticators for fetal academia in term pregnancies of laboring patients with suspected chorioamnioncitis” | Dr. Melisha Baldwin |
| 9:15 a.m. – 9:30 a.m. | BREAK | |
| 9:30 a.m. – 9:45 a.m. | “Inhibition of angiogenesis during hypoxia by knocking-out the expression of HIF-1? in ovarian cancer cells” | Dr. Christopher Bryant |
| 9:45 a.m. – 10:00 a.m. | “Lycopene a powerful antioxidant with remarkable antiadhesion effects” | Dr. Tarek Dbouk |
| 10:00 a.m. – 10:15 a.m. | “Ductus venosus SIA index and a-wave reversed flow in severly premature growth-restricted fetusus” | Dr. Jason Picconi |
| 10:15 a.m. – 10:30 a.m. | “Does a short cervix increase the risk for a small for gestational age neonate? | Dr. Vivian Romero |
| 10:30 a.m. – 10:45 a.m. | “Trends in sterilization since the introduction of essure hysteroscopic sterilization” | Dr. Valerie Shavell |
| 10:45 a.m. – 11:00 a.m. | “Evaluation of implantation in assisted reproduction in PCO and non-PCO patients through use of serial human chorionic gonadotropin measurements” | Dr. Jill Terry |
| 11:00 a.m. – 11:15 a.m. | “Methadone maintenance therapy during pregnancy: trends in postpartum dose adjustments” | Dr. Clara Ward |
| 11:15 a.m. – 11:30 a.m. | “A role for CXCL13 (BCA-1) in pregnancy and intra-amniotic infection/inflammation” | Dr. Chia-Ling Nhan-Chang |
| 11:30 a.m. – 11:45a.m. | “Accurate prenatal prediction of neonatal survival chances for pregnancies at borderline viability” | Dr. Mauro Schenone |